Skip to main content
. 2012 Nov 26;288(2):1409–1419. doi: 10.1074/jbc.M112.417717

FIGURE 5.

FIGURE 5.

The removal of an unexpected O-linked glycosylation modification is crucial to retaining the full anti-IL17A activity of the peptide-antibody scaffold. A, kinetic analysis with human IL17A. B, IL17A inhibition curves for the peptide-antibody fusion with either the original sequence (Q-GSE21-LC) or the threonine mutation to alanine (Q-GSE21-LC-T5A). Data shown are from a single representative experiment.